Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Wojciech Bartman"'
Autor:
Martyna Lis, Natalia Niedziela, Jowita Adamczyk-Zostawa, Krzysztof Wierzbicki, Zenon Czuba, Jolanta Zalejska-Fiolka, Wojciech Bartman, Agata Świętek, Monika Adamczyk-Sowa
Publikováno v:
Biomedicines, Vol 12, Iss 7, p 1580 (2024)
(1) Background: Studies indicate that vitamin D (VitD) may reduce inflammation in multiple sclerosis (MS). The aim of the study was to assess the effect of supplementation with different doses of VitD on inflammation in relapsing-remitting MS (RRMS)
Externí odkaz:
https://doaj.org/article/7fa388223be649d9959a38015496aab7
Autor:
Karolina Drożdż, Katarzyna Nabrdalik, Hanna Kwiendacz, Mirela Hendel, Anna Olejarz, Andrzej Tomasik, Wojciech Bartman, Jakub Nalepa, Janusz Gumprecht, Gregory Y. H. Lip
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-12 (2022)
Abstract Background Nonalcoholic fatty liver disease is associated with an increased cardiovascular disease (CVD) risk, although the exact mechanism(s) are less clear. Moreover, the relationship between newly redefined metabolic-associated fatty live
Externí odkaz:
https://doaj.org/article/cf35e9779eb14389bd392a98e1ec8e61
Autor:
Bożena Adamczyk, Natalia Morawiec, Gabriela Mamak, Sylwia Boczek, Dominika Brzęk, Natalia Trędota, Patryk Walocha, Zenon P. Czuba, Michał Błachut, Wojciech Bartman, Monika Adamczyk-Sowa
Publikováno v:
Diagnostics, Vol 13, Iss 22, p 3436 (2023)
Background: Multiple sclerosis (MS) is a chronic autoimmune disorder affecting the central nervous system (CNS). Due to the different phenotypes of the disease and non-specific symptoms of MS, there is a great need for a validated panel of biomarkers
Externí odkaz:
https://doaj.org/article/0f42bb5d975f48cb82fafc2b6ac853ca
Autor:
Hanna Kwiendacz, Katarzyna Nabrdalik, Agata M. Wijata, Wojciech Bartman, Elżbieta Tabor, Anna Olejarz, Joanna Król, Julia Piaśnik, Jakub Nalepa, Tomasz Stompór, Janusz Gumprecht, Gregory Y. H. Lip
Publikováno v:
Polish Archives of Internal Medicine.
Autor:
Wojciech Bartman, Natalia Niedziela, Krzysztof Wierzbicki, Bożena Adamczyk, Monika Adamczyk-Sowa, Katarzyna Kubicka-Bączyk, Maria Nowak-Kiczmer
Publikováno v:
Multiple Sclerosis and Related Disorders
Background It is suspected that patients with multiple sclerosis (MS) are at greater risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection due to disability and immunotherapy. The relationship between MS and coronavirus dise
Autor:
Krzysztof Wierzbicki, Bartosz Tadeusiak, Hubert Mado, Monika Adamczyk-Sowa, Wojciech Bartman, Paweł Sowa
Publikováno v:
Clinical neurology and neurosurgery. 206
BACKGROUND Cytokines and chemokines are undoubtedly involved in the pathogenesis of multiple sclerosis (MS). There are many reports that suggest a significant role for Interleukin-33 (IL-33) in the course of MS development, but it is not clear whethe
Autor:
Andrzej Tomasik, Wojciech Bartman, Janusz Gumprecht, Artur Chodkowski, Katarzyna Nabrdalik, Hanna Kwiendacz
Publikováno v:
Clinical Diabetology. 7:196-202
Introduction. Diabetic retinopathy (DR) is the leading cause of vision loss worldwide. Global prevalence of any diabetic retinopathy is assessed to be 35.4%. Several studies proved that chronic low-grade inflammation may be involved in the pathogenes
Publikováno v:
Neurological Sciences
The Klotho protein is a recently discovered protein and its overexpression is associated with life extension. Klotho deficiency or silencing of the Klotho gene in mice leads to an accelerated aging and short life, whereas overexpression of Klotho in
Autor:
Andrzej Tomasik, Hanna Kwiendacz, Katarzyna Nabrdalik, Władysław Grzeszczak, Wojciech Bartman, Janusz Gumprecht, Artur Chodkowski, Michał Kukla, Tomasz Sawczyn
Publikováno v:
Open Life Sciences, Vol 12, Iss 1, Pp 92-98 (2017)
Type 2 diabetes is contemporarily a major social and epidemiological problem and among others is a strong risk factor for cardiovascular diseases. Pentraxin 3, a potential early biomarker of atherosclerosis, is an acute-phase reactant produced by the
Autor:
Paweł Sowa, Monika Adamczyk-Sowa, Katarzyna Kubicka-Bączyk, Wojciech Bartman, Hubert Mado, Barbara Sobala-Szczygieł, Jerzy Jaroszewicz
Publikováno v:
Clinical Neurology and Neurosurgery
Highlights • MS-related disability is an independent risk factor for COVID-19 severity. • Most likely, disease-modifying therapy does not affect the severity of COVID-19. • Special caution should be applied when administering DMT causing lympho